APA

Fernanda Amary M., Ye H., Berisha F., Khatri B., Forbes G., Lehovsky K., Frezza A. M., Behjati S., Tarpey P., Pillay N., Campbell P. J., Tirabosco R., Presneau N., Strauss S. J. & Flanagan A. M. (20150330). Fibroblastic growth factor receptor 1 amplification in osteosarcoma is associated with poor response to neo-adjuvant chemotherapy. : Cancer medicine.

Chicago

Fernanda Amary M, Ye Hongtao, Berisha Fitim, Khatri Bhavisha, Forbes Georgina, Lehovsky Katie, Frezza Anna M, Behjati Sam, Tarpey Patrick, Pillay Nischalan, Campbell Peter J, Tirabosco Roberto, Presneau Nadège, Strauss Sandra J and Flanagan Adrienne M. 20150330. Fibroblastic growth factor receptor 1 amplification in osteosarcoma is associated with poor response to neo-adjuvant chemotherapy. : Cancer medicine.

Harvard

Fernanda Amary M., Ye H., Berisha F., Khatri B., Forbes G., Lehovsky K., Frezza A. M., Behjati S., Tarpey P., Pillay N., Campbell P. J., Tirabosco R., Presneau N., Strauss S. J. and Flanagan A. M. (20150330). Fibroblastic growth factor receptor 1 amplification in osteosarcoma is associated with poor response to neo-adjuvant chemotherapy. : Cancer medicine.

MLA

Fernanda Amary M, Ye Hongtao, Berisha Fitim, Khatri Bhavisha, Forbes Georgina, Lehovsky Katie, Frezza Anna M, Behjati Sam, Tarpey Patrick, Pillay Nischalan, Campbell Peter J, Tirabosco Roberto, Presneau Nadège, Strauss Sandra J and Flanagan Adrienne M. Fibroblastic growth factor receptor 1 amplification in osteosarcoma is associated with poor response to neo-adjuvant chemotherapy. : Cancer medicine. 20150330.